Drug Shortage Report for TWYNSTA
Report ID | 57591 |
Drug Identification Number | 02371022 |
Brand name | TWYNSTA |
Common or Proper name | TWYNSTA 40 + 5 MG |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | MARKETED |
Active Ingredient(s) | AMLODIPINE TELMISARTAN |
Strength(s) | 5MG 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 28s |
ATC code | C09DB |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-09-24 |
Actual start date | 2018-09-19 |
Estimated end date | 2018-10-29 |
Actual end date | 2018-10-31 |
Shortage status | Resolved |
Updated date | 2018-11-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2018-11-01 | English | Compare |
v10 | 2018-10-31 | English | Compare |
v9 | 2018-10-31 | French | Compare |
v8 | 2018-10-31 | English | Compare |
v7 | 2018-10-03 | French | Compare |
v6 | 2018-10-03 | English | Compare |
v5 | 2018-09-20 | English | Compare |
v4 | 2018-09-19 | French | Compare |
v3 | 2018-09-19 | English | Compare |
v2 | 2018-08-07 | French | Compare |
v1 | 2018-08-07 | English | Compare |
Showing 1 to 11 of 11